Plasma amyloid-beta oligomer and phosphorylated tau: diagnostic tools for progressive Alzheimer 's disease
摘要Introduction: Spanning the three stages of the Alzheimer's disease (AD) continuum, amyloid-beta (Aβ40 and Aβ42) oligomers (AβO's) and tau protein constitute a set of biomarkers ideally suited for the non-invasive monitoring of AD (Wolgin et al., 2022).
更多相关知识
- 浏览9
- 被引3
- 下载0

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文